TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
SRTS

Sensus Healthcare Inc

Healthcare · Medical Devices

3.00$ +1.7% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Sensus Healthcare Inc (SRTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 41 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SRTS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
18 19 19 19 18 19 20 20 33 33 34 36 36 37 32 30 28 28 26 26 26 32 54 56 55 57 53 52 51 54 57 58 60 62 60 59 58 53 52 41
15 17 18 18 17 18 19 19 31 32 32 33 33 34 30 27 25 25 24 24 24 31 48 51 52 53 49 47 46 50 54 54 55 57 54 52 50 46 43 38
4.6 5.0 3.1 4.2 6.8 10 9.5 8.0 17 12 6.3 11 6.9 8.1 12 18 16 15 14 15 16 15 33 34 38 26 19 20 20 23 15 19 23 22 19 22 24 22 18 15
9.5 12 11 11 9.9 11 9.5 8.0 17 15 11 17 15 15 16 19 16 15 14 15 16 15 33 34 38 26 19 20 20 23 15 19 23 22 19 22 24 22 18 15
3.9 3.1 4.2 4.8 5.1 5.0 8.1 8.0 11 13 17 12 13 14 7.8 1.1 1.3 3.8 4.1 4.6 4.1 12 11 10 7.4 17 13 9.1 6.9 11 20 18 17 20 18 13 9.3 6.0 3.6 1.7
1.3 1.3 1.5 1.6 1.7 1.2 1.2 1.6 2.0 1.6 1.6 2.1 2.3 3.0 4.0 5.5 5.3 4.4 4.3 3.1 2.0 1.8 2.3 1.7 2.4 3.5 6.3 10 13 12 15 13 12 10 9.9 12 13 15 17 18
0.5 0.4 0.5 0.5 0.4 0.4 0.6 0.8 1.0 0.9 1.6 2.5 2.6 2.5 2.4 2.2 1.5 1.4 1.2 1.7 0.9 0.8 0.4 1.5 1.5 0.2 0.4 0.4 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.7 0.6 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.4 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 – – – – – – – – – – –
3.0 3.7 5.4 6.0 6.1 7.2 9.2 9.5 6.3 6.8 6.5 8.5 9.0 8.9 7.8 7.6 7.3 6.5 6.0 6.1 5.0 6.2 11 11 7.6 8.7 7.1 6.0 6.0 4.9 6.1 5.3 5.7 6.3 7.2 6.8 7.1 4.9 6.0 4.4
3.0 3.7 5.4 6.0 6.1 7.1 5.0 4.9 5.8 6.0 5.2 6.0 6.5 6.5 5.6 4.8 4.8 4.9 4.7 5.2 4.8 6.0 10 10 6.6 7.7 6.2 5.2 5.2 4.2 5.5 4.7 5.2 5.9 6.7 6.4 6.8 4.7 5.9 4.3
– – 1.5 1.4 1.6 2.2 4.2 4.2 – – 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3
2.0 2.8 3.3 3.6 3.7 4.1 4.3 4.2 5.0 13 4.1 4.6 4.9 4.8 3.9 2.9 2.6 2.9 2.8 3.0 2.7 4.1 4.4 4.8 4.9 5.5 4.9 3.9 4.0 2.8 3.7 3.3 4.0 4.8 5.6 5.4 5.6 3.3 4.7 3.2
0.0 0.0 0.0 0.0 0.0 2.2 4.2 4.2 0.0 – 0.5 – – – – 1.0 1.0 0.3 0.2 – – – – – – – – – – – – – – – – – – – – –
15 15 14 13 12 12 11 11 26 26 27 27 27 28 25 22 20 21 20 20 21 26 42 45 47 48 46 46 45 49 51 53 54 56 53 52 51 48 46 37
-7.8 -7.8 -9.4 -10 -11 -12 -13 -13 -14 -14 -16 -16 -16 -15 -19 -21 -23 -22 -23 -23 -23 -18 -1.9 1.6 3.5 6.3 4.4 4.0 2.6 6.8 9.1 11 12 13 11 9.8 8.9 5.7 3.1 -5.7
13 14 13 13 13 13 13 13 14 16 16 16 16 16 16 16 16 16 16 16 16 17 17 17 17 17 16 16 16 16 16 16 16 16 16 16 16 16 16 16

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?